Steven D. Weisbord, MD, MSc, FASN
Dr. Steven Weisbord joined the VAPHS in 2004 after completing his fellowship in nephrology at the University of Pittsburgh Medical Center. Dr. Weisbord has several research areas of interest. He has conducted studies on the prevention of contrast-induced acute kidney injury and disparities in the use of contrast-enhanced procedures in patients with chronic kidney disease. He has a VA HSR&D Merit Review award that is investigating the impact of the MISSION Act on VA kidney and liver transplantation. He is also a Principal Investigator on an NIH-sponsored pilot trial investigating the role of urea for the treatment of chronic hyponatremia.
Renal-Electrolyte Division, University of Pittsburgh School of Medicine
What are the most important questions that define your research program?
What is the extent of the disparity in utilization of clinically-indicated contrast-enhanced procedures based on patients underlying level of kidney function?
What impact will the MISSION Act have on Veterans seeking kidney or liver transplantation and on the VA transplant program?
What are key words that best describe your areas of interest?
Acute kidney injury
What are up to 5 technologies, models, methods, analytical approaches or other forms of expertise that characterize your research program?
Observational cohort analyses